Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
about
Functional neuroimaging in Parkinson's diseasePriming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease.Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.Novel pharmacological strategies for motor complications in Parkinson's disease.Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.Non-human primate models of PD to test novel therapies.Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.Understanding and prevention of "therapy-" induced dyskinesias.Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease.Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque.Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Therapy for dyskinesias in Parkinson’s disease patients
P2860
Q27013767-5E7AB563-EAB3-4743-88F8-58AE7E7BECECQ34044620-0873B887-0B65-4E35-852C-93FD26BB7A50Q34101796-5C6F121A-5EBE-4790-9BFC-ACE32BA1D031Q35589979-89F2E903-7DE4-4776-9B04-90D05E8E57C4Q36120761-08EDC2FD-1C73-4E18-95CF-79CA3BE19C1DQ36543057-A0BB4A34-E7AA-41DD-A199-C186012B0F20Q37507973-04D80AC4-3E71-4355-A5D7-92491D9850FAQ38215506-39288EB2-0197-41C9-869B-613407DC7977Q38314257-3FCEE9C5-A7D6-40E7-929C-654EE215FC8DQ39229450-D9601DF5-C2F6-41E0-AE53-2388572C01E5Q40433968-C65C830A-7DEB-43AA-847A-5B64614E7BD3Q42052125-5160B4C2-DA5C-4459-B4A3-81EA05AC11DAQ42709834-AA6718F3-A440-44FF-A4C2-81731849C4CEQ45075694-9ACDE70D-97F0-46E3-9959-394BFAEA4D38Q45111646-0D0C72A9-5932-4A7A-A3C4-2BDCF8898938Q48171351-DFDBCC8A-4E52-4E3B-AB61-AD629D2B6D48Q57518128-C68D48E4-19C1-4F1E-AB83-9808AF8F5BEE
P2860
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effect of pulsatile administra ...... istration, and brain exposure.
@en
Effect of pulsatile administra ...... istration, and brain exposure.
@nl
type
label
Effect of pulsatile administra ...... istration, and brain exposure.
@en
Effect of pulsatile administra ...... istration, and brain exposure.
@nl
prefLabel
Effect of pulsatile administra ...... istration, and brain exposure.
@en
Effect of pulsatile administra ...... istration, and brain exposure.
@nl
P2093
P2860
P356
P1433
P1476
Effect of pulsatile administra ...... istration, and brain exposure.
@en
P2093
Eleni Maratos
Lance A Smith
Matthew J Hansard
Michael J Jackson
Peter Jenner
P2860
P304
P356
10.1002/MDS.10394
P407
P577
2003-05-01T00:00:00Z